1. Epigenetic modifications control loss of adhesion and aggressiveness of cancer stem cells derived from head and neck squamous cell carcinoma with intrinsic resistance to cisplatin
   Thaís Moré Milan et al, 2022, Archives of Oral Biology CrossRef
2. A novel role of TCAIM: suppressing renal carcinoma growth and enhancing its sensitivity to sunitinib
   Zhuo Ye et al, 2022, The FEBS Journal CrossRef
3. Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer
   Pengzhu Huang et al, 2023, Journal of Translational Medicine CrossRef
4. Histone deacetylase (HDACs) inhibitors: Clinical applications
   Kumar D. Shanmukha et al, 2023, Epigenetics in Health and Disease - Part B CrossRef
5. Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents
   Mehrdad Hashemi et al, 2023, Pharmacological Research CrossRef
6. Metabolic reprogramming and interventions in endometrial carcinoma
   Jiajia Li et al, 2023, Biomedicine & Pharmacotherapy CrossRef
7. LIN28B induced PCAT5 promotes endometrial cancer progression and glycolysis via IGF2BP3 deubiquitination
   Bin Wang et al, 2024, Cell Death & Disease CrossRef
8. Circular RNAs in endometrial carcinoma (Review)
   Shan Gao et al, 2022, Oncology Reports CrossRef
9. Advances in miR-331 Research in Human Cancer
   赫 云, 2024, Advances in Clinical Medicine CrossRef